Apelin Ameliorates TNF-α-Induced Reduction of Glycogen Synthesis in the Hepatocytes through G Protein-Coupled Receptor APJ

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Chu, Jiaojiao ^a,c   Zhang, Hangxiang ^a,b   Huang, Xiuqing ^a   Lin, Yajun ^a   Shen, Tao ^a   Chen, Beidong ^a   Man, Yong ^a   Wang, Shu ^a   Li, Jian ^a  

^a BEIJING HOSPITAL   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c ZHEJIANG HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APELIN; APELIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLYCOGEN ANALYSIS; GLYCOGEN LIVER LEVEL; GLYCOGEN SYNTHESIS; INSULIN RESISTANCE; LIVER CELL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; GENE EXPRESSION REGULATION; GLYCOGEN; HEP G2 CELLS; HEPATOCYTES; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; MICE; MICE, INBRED C57BL; PRIMARY CELL CULTURE; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874309903     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057231     Document Type: Article

References (41)

1. Goldstein BJ, (2002) Insulin resistance as the core defect in type 2 diabetes mellitus. Am J Cardiol 90: 3G-10G.
2. Lempiainen P, Mykkanen L, Pyorala K, Laakso M, Kuusisto J, (1999) Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 100: 123-128.
3. Mlinar B, Marc J, Janez A, Pfeifer M, (2007) Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta 375: 20-35.
4. Ingelsson E, Arnlov J, Lind L, Sundstrom J, (2006) Metabolic syndrome and risk for heart failure in middle-aged men. Heart 92: 1409-1413.
5. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, et al. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716.
6. Hotamisligil GS, Shargill NS, Spiegelman BM, (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91.
7. Liang H, Yin B, Zhang H, Zhang S, Zeng Q, et al. (2008) Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-alpha signaling protected Wistar rats from diet-induced obesity and insulin resistance. Endocrinology 149: 2943-2951.
8. Li L, He Q, Huang X, Man Y, Zhou Y, et al. (2010) NOX3-derived reactive oxygen species promote TNF-alpha-induced reductions in hepatocyte glycogen levels via a JNK pathway. FEBS Lett 584: 995-1000.
9. Rosen ED, Spiegelman BM, (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444: 847-853.
10. Boucher J, Masri B, Daviaud D, Gesta S, Guigne C, et al. (2005) Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146: 1764-1771.
11. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, et al. (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251: 471-476.
12. Medhurst AD, Jennings CA, Robbins MJ, Davis RP, Ellis C, et al. (2003) Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 84: 1162-1172.
13. Falcao-Pires I, Ladeiras-Lopes R, Leite-Moreira AF, (2010) The apelinergic system: a promising therapeutic target. Expert Opin Ther Targets 14: 633-645.
14. Sorhede Winzell M, Magnusson C, Ahren B, (2005) The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul Pept 131: 12-17.
15. Yue P, Jin H, Aillaud M, Deng AC, Azuma J, et al. (2010) Apelin is necessary for the maintenance of insulin sensitivity. Am J Physiol Endocrinol Metab 298: E59-67.
16. Dray C, Knauf C, Daviaud D, Waget A, Boucher J, et al. (2008) Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 8: 437-445.
17. Devic E, Rizzoti K, Bodin S, Knibiehler B, Audigier Y, (1999) Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ. Mech Dev 84: 199-203.
18. Li L, Yang G, Li Q, Tang Y, Yang M, et al. (2006) Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes 114: 544-548.
19. Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, Garcia-Almeida JM, Garcia-Arnes J, et al. (2009) Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obes Surg 19: 1574-1580.
20. Daviaud D, Boucher J, Gesta S, Dray C, Guigne C, et al. (2006) TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J 20: 1528-1530.
21. Erdem G, Dogru T, Tasci I, Sonmez A, Tapan S, (2008) Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 116: 289-292.
22. Zhang Y, Shen C, Li X, Ren G, Fan X, et al. (2009) Low plasma apelin in newly diagnosed type 2 diabetes in Chinese people. Diabetes Care 32: e150.
23. Kadoglou NP, Tsanikidis H, Kapelouzou A, Vrabas I, Vitta I, et al. (2010) Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus. Metabolism 59: 373-379.
24. Xu S, Tsao PS, Yue P, (2011) Apelin and insulin resistance: another arrow for the quiver? J Diabetes 3: 225-231.
25. Castan-Laurell I, Dray C, Attane C, Duparc T, Knauf C, et al. (2011) Apelin, diabetes, and obesity. Endocrine 40: 1-9.
26. Gao D, Nong S, Huang X, Lu Y, Zhao H, et al. (2010) The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. J Biol Chem 285: 29965-29973.
27. Higuchi K, Masaki T, Gotoh K, Chiba S, Katsuragi I, et al. (2007) Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology 148: 2690-2697.
28. Kleinz MJ, Davenport AP, (2004) Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul Pept 118: 119-125.
29. Glassford AJ, Yue P, Sheikh AY, Chun HJ, Zarafshar S, et al. (2007) HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes. Am J Physiol Endocrinol Metab 293: E1590-1596.
30. Kleinz MJ, Davenport AP, (2005) Emerging roles of apelin in biology and medicine. Pharmacol Ther 107: 198-211.
31. Katakam AK, Chipitsyna G, Gong Q, Vancha AR, Gabbeta J, et al. (2005) Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production. J Endocrinol 187: 237-247.
32. Bloch-Damti A, Bashan N, (2005) Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid Redox Signal 7: 1553-1567.
33. Hung WW, Hsieh TJ, Lin T, Chou PC, Hsiao PJ, et al. (2011) Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes. Cardiovasc Drugs Ther 25: 3-12.
34. Foussal C, Lairez O, Calise D, Pathak A, Guilbeau-Frugier C, et al. (2010) Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy. FEBS Lett 584: 2363-2370.
35. Zeng XJ, Yu SP, Zhang L, Wei L, (2010) Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons. Exp Cell Res 316: 1773-1783.
36. O'Dowd BF, Heiber M, Chan A, Heng HH, Tsui LC, et al. (1993) A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136: 355-360.
37. Katugampola SD, Maguire JJ, Matthewson SR, Davenport AP, (2001) [(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. Br J Pharmacol 132: 1255-1260.
38. Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, et al. (2001) Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 1538: 162-171.
39. Lee DK, Saldivia VR, Nguyen T, Cheng R, George SR, et al. (2005) Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology 146: 231-236.
40. Seglen PO, (1976) Preparation of isolated rat liver cells. Methods Cell Biol 13: 29-83.
41. Casciano DA, (2000) Development and utilization of primary hepatocyte culture systems to evaluate metabolism, DNA binding, and DNA repair of xenobiotics. Drug Metab Rev 32: 1-13.